概览
Conference: March 14-15, 2024
DIA’s Global Labeling Conference is designed for professionals in medical product labeling and related disciplines as they work to develop and manage clear and accurate labeling information for the safe and effective use of prescription drugs, biologics, and medical devices. The efforts of these professionals are key to providing essential information needed by providers, patients, and payers to make decisions about product access, prescription, and use. Influences such as digital technology, patient centricity, evolving product classes, and changing regulations require the use of informed, systematic approaches throughout the labeling cycle to ensure the development and availability of current, compliant information in all regions where products are marketed.
This conference provides a forum for exchange among regulators and industry peers to update their knowledge of key local and global labeling policies and to examine the impact of changes on regulatory compliance. Most importantly, through interactive discussions with expert panels and peer-to-peer exchange, participants will share approaches, processes, and tools to ensure the availability of effective labeling content meeting the needs of patients, consumers, and prescribers.
Participant Testimonials
A fantastic opportunity to hear from the experts on the latest developments and best practices in the labelling area. – Suzanna Leacy, Director, Global Labeling Development, GSK
An excellent labeling conference. The speakers were excellent and knowledgeable. The sessions were the correct amount of time. I will definitely attend next year. – Carolyn McKelvie, Engagement Director, Luto Research
Welcome Video!
项目委员会
-
Kathleen Salazar, MA, MBA Head, Global Labeling Implementation
Johnson & Johnson Innovative Medicine, United States -
Rie Matsui, RPh Senior Director, Regional Labeling Head for APAC, International Labeling
Pfizer R&D Japan G.K., Japan -
Deborah Bebbington Head Global Labeling
Bayer Plc, United Kingdom -
Lauren Brunke, PharmD, RPh Senior Director, Global Regulatory Affairs, Global Labeling
Eli Lilly and Company, United States -
Theresa Brunone, MLS, MS Head-Labelling Compliance and Implementation, Global Labeling
GlaxoSmithKline, United States -
Megann Looker Executive Director, Head of Global Labeling
Jazz Pharmaceuticals, United Kingdom -
Gerrit Nijveldt, MS, MSc Global Labeling Consultant
Opus Regulatory Inc., United States -
Hayley Parker, PhD, MSc Senior Vice President
Pepgen Inc., United States -
Mary Beth Wilusz Head, Regulatory Labeling Operations and Compliance
Daiichi Sankyo, Inc., United States -
Representative Invited DIA, United States
-
Steven Bass, PhD President
United States -
Su-Yueh Lin Sr. Labeling Consultant, Regulatory Affairs
SYL Regulatory Consulting, Taiwan